KRISTEN OCHSNER: Open Payments
NPI 1265697510 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,432 in 95 payments from 11 companies in 2025. Trend: 2023 $703 · 2024 $1,227 · 2025 $1,432
Food & beverage: $1,357Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $407 |
| ABBVIE INC. | 24 | $374 |
| Novartis Pharmaceuticals Corporation | 8 | $160 |
| E.R. Squibb & Sons, L.L.C. | 13 | $139 |
| UCB, Inc. | 14 | $135 |
| Amgen Inc. | 5 | $89 |
| Lilly USA, LLC | 3 | $46 |
| STRATA Skin Sciences, Inc. | 2 | $31 |
| Incyte Corporation | 1 | $20 |
| Journey Medical Corporation | 1 | $16 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Sotyktu, Bimzelx, OTEZLA, COSENTYX, Rhapsido.
Industry payments across KS — which companies pay providers there.
